Toledano Miranda Jayne 4

What Happened
Toledano Miranda Jayne, a director of Journey Medical Corp (DERM), was granted 50,000 restricted stock units (RSUs) on July 1, 2026. The grant is reported at $0.00 (no cash exchanged) and represents an award under the company's 2015 Stock Plan. This is a grant/award (not a purchase or sale) and does not represent an immediate change in tradable shares.

Key Details

• Transaction date: July 1, 2026; Filing date (Form 4): July 2, 2026 (timely filing).
• Amount: 50,000 RSUs granted; reported price $0.00 (Acquired = $0).
• Vesting schedule (Footnote F1): 16,666 RSUs vest on July 1, 2029; 16,667 on July 1, 2030; 16,667 on July 1, 2031.
• Footnote F2: Confirms these are restricted stock units that vest over time.
• Shares owned after transaction: Not specified in the provided filing details.

Context
RSUs are awards that convert into shares only as they vest; they are not immediately transferable and their ultimate value depends on Journey Medical's share price at vesting. Grants to directors are common as compensation/retention — factual disclosure rather than a direct buy or sell signal. The filing appears timely (filed the day after the grant).